Collegium Pharmaceutical, Inc. (COLL) vs Olema Pharmaceuticals, Inc. (OLMA)

A side-by-side comparison of Collegium Pharmaceutical, Inc. and Olema Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — COLL vs OLMA

growth of $100 · dividends reinvested · last 6y
COLL +14.4% (+2.3%/yr)OLMA -83.2% (-25.7%/yr)COLL compounded faster over this window
Log scale — wide-divergence pair
1101001kStart $100202120222023202420252026$114$17
COLL OLMA

COLL vs OLMA: by the numbers

  • •COLL is the larger company ($709M vs $688M market cap).
  • •COLL is profitable (5.93% net margin) while OLMA runs a net loss (0.00%).

Metrics side by side

Valuation

MetricCOLLOLMA
P/E ratio17.64N/A
PEG ratio0.99N/A
P/S ratio0.88N/A
P/B ratio2.271.60
EV / EBITDA2.84N/A
FCF yield46.28%N/A

Profitability

MetricCOLLOLMA
Gross margin60.02%0.00%
Operating margin19.61%0.00%
Net margin5.93%0.00%
ROE15.36%-47.51%
ROIC6.11%-50.92%

Growth (annualized)

MetricCOLLOLMA
Revenue CAGR (5Y)19.91%N/A
EPS CAGR (5Y)20.48%N/A
FCF CAGR (5Y)26.38%N/A
Total return CAGR (5Y)2.15%-21.50%

Frequently asked

Is COLL or OLMA more profitable?
COLL runs the higher net margin — COLL at 5.93% versus OLMA at 0.00%.
How have COLL and OLMA total returns compared?
Over the past 5 years, COLL delivered 2.15% and OLMA delivered -21.50% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.